Alzamend Neuro Inc expected to post a loss of 67 cents a share - Earnings Preview

Alzamend Neuro

15/12/2023 21:09

* Alzamend Neuro Inc  ALZN.OQ   ALZN.O  is expected to show
no
change in quarterly revenue when it reports  results on December
18 (estimated) for the period ending July 31 2023
    * 
    * ​LSEG's mean analyst estimate for Alzamend Neuro Inc is
for a
loss of 67 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Alzamend
Neuro
Inc is $56.25​, above​ its last closing price of $1.05. ​​​

This summary was machine generated December 15 at 21:09 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)